(Q44146736)

30 November 2017

0 references

Ivermectin as a complementary strategy to kill mosquitoes and stop malaria transmission? (English)

1 reference

30 November 2017

0 references

0 references

2

1 reference

30 November 2017

1

Richard W Steketee

1 reference

30 November 2017

language of work or name

English

0 references

publication date

19 November 2014

1 reference

Clinical Infectious Diseases

30 November 2017

published in

1 reference

30 November 2017

volume

60

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

366-368

1 reference

Endectocides for malaria control

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

The effects of high-dose ivermectin regimens on Onchocerca volvulus in onchocerciasis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU802

21 January 2018

Identifiers

DOI

10.1093/CID/CIU802

1 reference

30 November 2017

1 reference